Status:

COMPLETED

Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection

Lead Sponsor:

University of Giessen

Collaborating Sponsors:

Heidelberg University

Astellas Pharma Inc

Conditions:

Renal Failure, Chronic

Eligibility:

All Genders

14+ years

Brief Summary

Chronic transplant rejection remains the main cause of late kidney graft loss. We showed previously that patients with pretransplant CD4 helper defects and low in-vitro IL-10 responses demonstrated an...

Detailed Description

Chronic transplant rejection remains the main cause of late kidney graft loss. We showed previously that patients with pretransplant CD4 helper defects and low in-vitro IL-10 responses demonstrated an...

Eligibility Criteria

Inclusion

  • Renal transplant recipients in the Giessen renal transplant unit

Exclusion

  • Contraindications against blood-taking (anemia with hemoglobin\<9.5 g/l, hypotension etc.)
  • No informed consent by the patient

Key Trial Info

Start Date :

January 1 1998

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2006

Estimated Enrollment :

84 Patients enrolled

Trial Details

Trial ID

NCT00150891

Start Date

January 1 1998

End Date

January 1 2006

Last Update

May 10 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Internal Medicine, University of Giessen

Giessen, Germany, D-35392